planet pathology limited
planet pathology limited Company Information
Company Number
07699622
Next Accounts
Apr 2025
Industry
Other human health activities
Shareholders
rezan gardy
kamaran kakel
Group Structure
View All
Contact
Registered Address
q west c/o agp consulting, great west road, brentford, TW8 0GP
Website
www.planetpathology.co.ukplanet pathology limited Estimated Valuation
Pomanda estimates the enterprise value of PLANET PATHOLOGY LIMITED at £1.8m based on a Turnover of £3.8m and 0.48x industry multiple (adjusted for size and gross margin).
planet pathology limited Estimated Valuation
Pomanda estimates the enterprise value of PLANET PATHOLOGY LIMITED at £2m based on an EBITDA of £543.7k and a 3.64x industry multiple (adjusted for size and gross margin).
planet pathology limited Estimated Valuation
Pomanda estimates the enterprise value of PLANET PATHOLOGY LIMITED at £3m based on Net Assets of £1.2m and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Planet Pathology Limited Overview
Planet Pathology Limited is a live company located in brentford, TW8 0GP with a Companies House number of 07699622. It operates in the other human health activities sector, SIC Code 86900. Founded in July 2011, it's largest shareholder is rezan gardy with a 50% stake. Planet Pathology Limited is a established, small sized company, Pomanda has estimated its turnover at £3.8m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Planet Pathology Limited Health Check
Pomanda's financial health check has awarded Planet Pathology Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs
6 Strong
1 Regular
3 Weak
Size
annual sales of £3.8m, make it larger than the average company (£662.9k)
- Planet Pathology Limited
£662.9k - Industry AVG
Growth
3 year (CAGR) sales growth of 21%, show it is growing at a faster rate (5.7%)
- Planet Pathology Limited
5.7% - Industry AVG
Production
with a gross margin of 21.4%, this company has a higher cost of product (38.7%)
- Planet Pathology Limited
38.7% - Industry AVG
Profitability
an operating margin of 14.4% make it more profitable than the average company (5.7%)
- Planet Pathology Limited
5.7% - Industry AVG
Employees
with 3 employees, this is below the industry average (17)
3 - Planet Pathology Limited
17 - Industry AVG
Pay Structure
on an average salary of £25.8k, the company has an equivalent pay structure (£25.8k)
- Planet Pathology Limited
£25.8k - Industry AVG
Efficiency
resulting in sales per employee of £1.3m, this is more efficient (£48.1k)
- Planet Pathology Limited
£48.1k - Industry AVG
Debtor Days
it gets paid by customers after 148 days, this is later than average (24 days)
- Planet Pathology Limited
24 days - Industry AVG
Creditor Days
its suppliers are paid after 38 days, this is slower than average (19 days)
- Planet Pathology Limited
19 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Planet Pathology Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Planet Pathology Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 21.6%, this is a lower level of debt than the average (26%)
21.6% - Planet Pathology Limited
26% - Industry AVG
PLANET PATHOLOGY LIMITED financials
Planet Pathology Limited's latest turnover from July 2023 is estimated at £3.8 million and the company has net assets of £1.2 million. According to their latest financial statements, Planet Pathology Limited has 3 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | Jul 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||||
| Other Income Or Grants | ||||||||||||
| Cost Of Sales | ||||||||||||
| Gross Profit | ||||||||||||
| Admin Expenses | ||||||||||||
| Operating Profit | ||||||||||||
| Interest Payable | ||||||||||||
| Interest Receivable | ||||||||||||
| Pre-Tax Profit | ||||||||||||
| Tax | ||||||||||||
| Profit After Tax | ||||||||||||
| Dividends Paid | ||||||||||||
| Retained Profit | ||||||||||||
| Employee Costs | ||||||||||||
| Number Of Employees | 3 | 3 | 3 | 2 | 2 | |||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | Jul 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 10,501 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 10,501 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 1,543,597 | 1,146,240 | 874,268 | 766,848 | 393,970 | 79,346 | 89,690 | 67,629 | 80,100 | 31,606 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,469 | 5,170 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1,543,597 | 1,146,240 | 874,268 | 766,848 | 393,970 | 79,346 | 89,690 | 67,629 | 80,100 | 31,606 | 4,469 | 5,170 |
| total assets | 1,554,098 | 1,146,240 | 874,268 | 766,848 | 393,970 | 79,346 | 89,690 | 67,629 | 80,100 | 31,606 | 4,469 | 5,170 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 316,300 | 305,306 | 283,996 | 254,103 | 166,015 | 4,840 | 12,549 | 13,184 | 46,931 | 24,744 | 2,123 | 2,531 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 316,300 | 305,306 | 283,996 | 254,103 | 166,015 | 4,840 | 12,549 | 13,184 | 46,931 | 24,744 | 2,123 | 2,531 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 19,081 | 29,995 | 38,432 | 50,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 19,081 | 29,995 | 38,432 | 50,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 335,381 | 335,301 | 322,428 | 304,103 | 166,015 | 4,840 | 12,549 | 13,184 | 46,931 | 24,744 | 2,123 | 2,531 |
| net assets | 1,218,717 | 810,939 | 551,840 | 462,745 | 227,955 | 74,506 | 77,141 | 54,445 | 33,169 | 6,862 | 2,346 | 2,639 |
| total shareholders funds | 1,218,717 | 810,939 | 551,840 | 462,745 | 227,955 | 74,506 | 77,141 | 54,445 | 33,169 | 6,862 | 2,346 | 2,639 |
| Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Jul 2019 | Jul 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Jul 2014 | Jul 2013 | Jul 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Operating Profit | ||||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Tax | ||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 397,357 | 271,972 | 107,420 | 372,878 | 314,624 | -10,344 | 22,061 | -12,471 | 48,494 | 31,606 | 0 | 0 |
| Creditors | 10,994 | 21,310 | 29,893 | 88,088 | 161,175 | -7,709 | -635 | -33,747 | 22,187 | 22,621 | -408 | 2,531 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||||
| Investing Activities | ||||||||||||
| capital expenditure | ||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||
| Financing Activities | ||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | -10,914 | -8,437 | -11,568 | 50,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||
| interest | ||||||||||||
| cash flow from financing | ||||||||||||
| cash and cash equivalents | ||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4,469 | -701 | 5,170 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4,469 | -701 | 5,170 |
planet pathology limited Credit Report and Business Information
Planet Pathology Limited Competitor Analysis
Perform a competitor analysis for planet pathology limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in TW8 area or any other competitors across 12 key performance metrics.
planet pathology limited Ownership
PLANET PATHOLOGY LIMITED group structure
Planet Pathology Limited has 2 subsidiary companies.
Ultimate parent company
PLANET PATHOLOGY LIMITED
07699622
2 subsidiaries
planet pathology limited directors
Planet Pathology Limited currently has 2 directors. The longest serving directors include Mrs Rezan Gardy (Jul 2011) and Mr Kamaran Kakel (Apr 2015).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Rezan Gardy | United Kingdom | 59 years | Jul 2011 | - | Director |
| Mr Kamaran Kakel | United Kingdom | 55 years | Apr 2015 | - | Director |
P&L
July 2023turnover
3.8m
+38%
operating profit
543.7k
0%
gross margin
21.5%
-0.17%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
July 2023net assets
1.2m
+0.5%
total assets
1.6m
+0.36%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
planet pathology limited company details
company number
07699622
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
July 2011
age
13
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
July 2023
previous names
N/A
accountant
-
auditor
-
address
q west c/o agp consulting, great west road, brentford, TW8 0GP
Bank
-
Legal Advisor
-
planet pathology limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to planet pathology limited.
planet pathology limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PLANET PATHOLOGY LIMITED. This can take several minutes, an email will notify you when this has completed.
planet pathology limited Companies House Filings - See Documents
| date | description | view/download |
|---|
